{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:01:24Z","timestamp":1784394084038,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.4158\/ep14141.cr","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T22:44:57Z","timestamp":1402958697000},"page":"e187-e190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Atypical Femoral Fracture in an Osteogenesis Imperfecta Patient Successfully Treated with Teriparatide"],"prefix":"10.1016","volume":"20","author":[{"given":"Jakob","family":"Holm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Eiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Hyldstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Erik Beck","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP14141.CR_bb0005","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet."},{"key":"10.4158\/EP14141.CR_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J Med Genet."},{"key":"10.4158\/EP14141.CR_bb0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.paed.2009.11.008","article-title":"Diagnosing osteogenesis imperfecta","volume":"20","author":"Arundel","year":"2010","journal-title":"Paediatr Child Health. (Oxf)."},{"key":"10.4158\/EP14141.CR_bb0020","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14141.CR_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11914-011-0065-0","article-title":"Effects of anti-osteoporosis medications on fracture healing","volume":"9","author":"J\u00f8rgensen","year":"2011","journal-title":"Curr Osteoporos Rep."},{"key":"10.4158\/EP14141.CR_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday","volume":"126","author":"McClung","year":"2013","journal-title":"Am J Med."},{"key":"10.4158\/EP14141.CR_bb0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution","volume":"89","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg Br."},{"key":"10.4158\/EP14141.CR_bb0040","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMc062268","article-title":"Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis","volume":"355","author":"Armamento-Villareal","year":"2006","journal-title":"N Engl J Med."},{"key":"10.4158\/EP14141.CR_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-010-9360-5","article-title":"Parathyroid hormone and bone healing","volume":"87","author":"Ellegaard","year":"2010","journal-title":"Calcif Tissue Int."},{"key":"10.4158\/EP14141.CR_bb0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00223-012-9587-4","article-title":"Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper","volume":"90","author":"Goldhahn","year":"2012","journal-title":"Calcif Tissue Int."},{"key":"10.4158\/EP14141.CR_bb0055","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/jbmr.1957","article-title":"The effect of PTH(1-34) on fracture healing during different loading conditions","volume":"28","author":"Ellegaard","year":"2013","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP14141.CR_bb0060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1359\/jbmr.090731","article-title":"Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures","volume":"25","author":"Aspenberg","year":"2010","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP14141.CR_bb0065","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/17453674.2012.729183","article-title":"Atypical femoral fracture following bisphosphonate treatment in a woman with osteogenesis imperfecta--a case report","volume":"83","author":"Meier","year":"2012","journal-title":"Acta Orthop."},{"key":"10.4158\/EP14141.CR_bb0070","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jc.2012-4195","article-title":"The paradox of prevention--bilateral atypical subtrochanteric fractures due to bisphosphonates in osteogenesis imperfecta","volume":"98","author":"Manolopoulos","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14141.CR_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the american society for bone and mineral research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP14141.CR_bb0080","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/gme.0b013e318260143d","article-title":"Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report","volume":"19","author":"Huang","year":"2012","journal-title":"Menopause."},{"key":"10.4158\/EP14141.CR_bb0085","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1210\/jc.2010-2520","article-title":"Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy","volume":"96","author":"Gomberg","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP14141.CR_bb0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI71101","article-title":"Evaluation of teriparatide treatment in adults with osteogenesis imperfecta","volume":"124","author":"Orwoll","year":"2014","journal-title":"J Clin Invest"},{"key":"10.4158\/EP14141.CR_bb0095","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1359\/jbmr.2002.17.11.2038","article-title":"Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34)","volume":"17","author":"Nakajima","year":"2002","journal-title":"J Bone Miner Res."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20421135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20421135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/U2N30117782TM24W.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:58:17Z","timestamp":1761515897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20421135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1530891X20421135"],"URL":"https:\/\/doi.org\/10.4158\/ep14141.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical Femoral Fracture in an Osteogenesis Imperfecta Patient Successfully Treated with Teriparatide","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP14141.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}